771 related articles for article (PubMed ID: 20682689)
1. Obesity is a fibroblast growth factor 21 (FGF21)-resistant state.
Fisher FM; Chui PC; Antonellis PJ; Bina HA; Kharitonenkov A; Flier JS; Maratos-Flier E
Diabetes; 2010 Nov; 59(11):2781-9. PubMed ID: 20682689
[TBL] [Abstract][Full Text] [Related]
2. Lack of overt FGF21 resistance in two mouse models of obesity and insulin resistance.
Hale C; Chen MM; Stanislaus S; Chinookoswong N; Hager T; Wang M; Véniant MM; Xu J
Endocrinology; 2012 Jan; 153(1):69-80. PubMed ID: 22067317
[TBL] [Abstract][Full Text] [Related]
3. Acute glucose-lowering and insulin-sensitizing action of FGF21 in insulin-resistant mouse models--association with liver and adipose tissue effects.
Xu J; Stanislaus S; Chinookoswong N; Lau YY; Hager T; Patel J; Ge H; Weiszmann J; Lu SC; Graham M; Busby J; Hecht R; Li YS; Li Y; Lindberg R; Véniant MM
Am J Physiol Endocrinol Metab; 2009 Nov; 297(5):E1105-14. PubMed ID: 19706786
[TBL] [Abstract][Full Text] [Related]
4. Fibroblast growth factor 21 reverses hepatic steatosis, increases energy expenditure, and improves insulin sensitivity in diet-induced obese mice.
Xu J; Lloyd DJ; Hale C; Stanislaus S; Chen M; Sivits G; Vonderfecht S; Hecht R; Li YS; Lindberg RA; Chen JL; Jung DY; Zhang Z; Ko HJ; Kim JK; Véniant MM
Diabetes; 2009 Jan; 58(1):250-9. PubMed ID: 18840786
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of β-Klotho in Adipose Tissue Sensitizes Male Mice to Endogenous FGF21 and Provides Protection From Diet-Induced Obesity.
Samms RJ; Cheng CC; Kharitonenkov A; Gimeno RE; Adams AC
Endocrinology; 2016 Apr; 157(4):1467-80. PubMed ID: 26901091
[TBL] [Abstract][Full Text] [Related]
6. Maresin 1 Regulates Hepatic FGF21 in Diet-Induced Obese Mice and in Cultured Hepatocytes.
Martínez-Fernández L; González-Muniesa P; Sáinz N; Laiglesia LM; Escoté X; Martínez JA; Moreno-Aliaga MJ
Mol Nutr Food Res; 2019 Dec; 63(24):e1900358. PubMed ID: 31576649
[TBL] [Abstract][Full Text] [Related]
7. FGF21 does not require adipocyte AMP-activated protein kinase (AMPK) or the phosphorylation of acetyl-CoA carboxylase (ACC) to mediate improvements in whole-body glucose homeostasis.
Mottillo EP; Desjardins EM; Fritzen AM; Zou VZ; Crane JD; Yabut JM; Kiens B; Erion DM; Lanba A; Granneman JG; Talukdar S; Steinberg GR
Mol Metab; 2017 Jun; 6(6):471-481. PubMed ID: 28580278
[TBL] [Abstract][Full Text] [Related]
8. Fibroblast Growth Factor 21 (FGF21) Administration Sex-Specifically Affects Blood Insulin Levels and Liver Steatosis in Obese
Makarova E; Kazantseva A; Dubinina A; Denisova E; Jakovleva T; Balybina N; Bgatova N; Baranov K; Bazhan N
Cells; 2021 Dec; 10(12):. PubMed ID: 34943946
[TBL] [Abstract][Full Text] [Related]
9. Intestinal serine protease inhibition increases FGF21 and improves metabolism in obese mice.
Albarazanji K; Jennis M; Cavanaugh CR; Lang W; Singh B; Lanter JC; Lenhard JM; Hornby PJ
Am J Physiol Gastrointest Liver Physiol; 2019 May; 316(5):G653-G667. PubMed ID: 30920846
[TBL] [Abstract][Full Text] [Related]
10. Increased fibroblast growth factor 21 in obesity and nonalcoholic fatty liver disease.
Dushay J; Chui PC; Gopalakrishnan GS; Varela-Rey M; Crawley M; Fisher FM; Badman MK; Martinez-Chantar ML; Maratos-Flier E
Gastroenterology; 2010 Aug; 139(2):456-63. PubMed ID: 20451522
[TBL] [Abstract][Full Text] [Related]
11. The Same Metabolic Response to FGF21 Administration in Male and Female Obese Mice Is Accompanied by Sex-Specific Changes in Adipose Tissue Gene Expression.
Makarova E; Kazantseva A; Dubinina A; Jakovleva T; Balybina N; Baranov K; Bazhan N
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638898
[TBL] [Abstract][Full Text] [Related]
12. Fibroblast growth factor-21 and the beneficial effects of long-chain n-3 polyunsaturated fatty acids.
Villarroya J; Flachs P; Redondo-Angulo I; Giralt M; Medrikova D; Villarroya F; Kopecky J; Planavila A
Lipids; 2014 Nov; 49(11):1081-9. PubMed ID: 25204579
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics (PK), pharmacodynamics (PD) and integrated PK/PD modeling of a novel long acting FGF21 clinical candidate PF-05231023 in diet-induced obese and leptin-deficient obese mice.
Weng Y; Chabot JR; Bernardo B; Yan Q; Zhu Y; Brenner MB; Vage C; Logan A; Calle R; Talukdar S
PLoS One; 2015; 10(3):e0119104. PubMed ID: 25790234
[TBL] [Abstract][Full Text] [Related]
14. A very low carbohydrate ketogenic diet improves glucose tolerance in ob/ob mice independently of weight loss.
Badman MK; Kennedy AR; Adams AC; Pissios P; Maratos-Flier E
Am J Physiol Endocrinol Metab; 2009 Nov; 297(5):E1197-204. PubMed ID: 19738035
[TBL] [Abstract][Full Text] [Related]
15. Serum FGF21 levels are increased in obesity and are independently associated with the metabolic syndrome in humans.
Zhang X; Yeung DC; Karpisek M; Stejskal D; Zhou ZG; Liu F; Wong RL; Chow WS; Tso AW; Lam KS; Xu A
Diabetes; 2008 May; 57(5):1246-53. PubMed ID: 18252893
[TBL] [Abstract][Full Text] [Related]
16. Opposite alterations in FGF21 and FGF19 levels and disturbed expression of the receptor machinery for endocrine FGFs in obese patients.
Gallego-Escuredo JM; Gómez-Ambrosi J; Catalan V; Domingo P; Giralt M; Frühbeck G; Villarroya F
Int J Obes (Lond); 2015 Jan; 39(1):121-9. PubMed ID: 24813368
[TBL] [Abstract][Full Text] [Related]
17. Fibroblast growth factor-21 (FGF21) administration to early-lactating dairy cows. II. Pharmacokinetics, whole-animal performance, and lipid metabolism.
Caixeta LS; Giesy SL; Krumm CS; Perfield JW; Butterfield A; Boisclair YR
J Dairy Sci; 2019 Dec; 102(12):11597-11608. PubMed ID: 31548064
[TBL] [Abstract][Full Text] [Related]
18. The FGF21 response to fructose predicts metabolic health and persists after bariatric surgery in obese humans.
Ter Horst KW; Gilijamse PW; Demirkiran A; van Wagensveld BA; Ackermans MT; Verheij J; Romijn JA; Nieuwdorp M; Maratos-Flier E; Herman MA; Serlie MJ
Mol Metab; 2017 Nov; 6(11):1493-1502. PubMed ID: 29107295
[TBL] [Abstract][Full Text] [Related]
19. Association between insulin resistance and impairment of FGF21 signal transduction in skeletal muscles.
Jeon JY; Choi SE; Ha ES; Kim TH; Jung JG; Han SJ; Kim HJ; Kim DJ; Kang Y; Lee KW
Endocrine; 2016 Jul; 53(1):97-106. PubMed ID: 26758997
[TBL] [Abstract][Full Text] [Related]
20. Fibroblast growth factor 21 increases insulin sensitivity through specific expansion of subcutaneous fat.
Li H; Wu G; Fang Q; Zhang M; Hui X; Sheng B; Wu L; Bao Y; Li P; Xu A; Jia W
Nat Commun; 2018 Jan; 9(1):272. PubMed ID: 29348470
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
